Employees: 1,695
Size KMC Speciality Hospitals (India) (KMCSHIL.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $346M, the 1006th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹197.42 on 18 Nov 2026.
Growth Revenue grew 35.0% over the last twelve months (peer median +10.9%); the operating margin is 23.4% (peer median 10.2%).
Valuation It trades at 9.8× enterprise value to sales against a peer median of 2.4× (most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +24%, so the hurdle is -5 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 15.3 points above its cost of capital (9.4% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹3.31B | ₹3.06B | ₹2.32B | ₹1.77B | ₹1.56B |
| Revenue growth | — | +32% | +31% | +14% | — |
| Gross profit | ₹1.91B | ₹858M | ₹550M | ₹479M | ₹431M |
| EBITDA | ₹1,000M | ₹892M | ₹582M | ₹484M | ₹422M |
| Net income | ₹558M | ₹467M | ₹214M | ₹304M | ₹267M |
| Free cash flow | n/a | ₹562M | -₹147M | -₹405M | -₹107M |
| Capital expenditure | n/a | ₹166M | ₹639M | ₹753M | ₹441M |
| Total debt | ₹828M | ₹837M | ₹894M | ₹818M | ₹499M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | KMCSHIL.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +25.8% | -2.1% | 2nd highest of 20 |
| Distance from 52-week high | -1.3% | -22.3% | 2nd highest of 21 |
| Revenue growth (TTM) | +35.0% | +10.9% | highest of 21 |
| Operating margin | 23.4% | 10.2% | 2nd highest of 21 |
| EV / Sales | 9.8× | 2.4× | most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 19.0% | 6.5% | 4th most demanding of 17 |
| Growth delivered (Del g) | +24.4% | +15.5% | 2nd highest of 17 |
| Hurdle (Req g minus delivered) | -5.4 pp | -6.6 pp | 9th least demanding of 17 |
| ROIC minus cost of capital | +15.3 pp | +0.6 pp | 3rd highest of 21 |
| EV / EBITDA | 32.4× | 12.9× | most expensive of 18 |
| Net debt / EBITDA | 0.1× | 0.6× | 8th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| KMC Speciality Hospitals (India) KMCSHIL.NS | India | $346M | n/a | +35% | 23% | 9.8× | 19.0% | +24.4% |
| Liaoning He Eye Hospital 301103.SZ | China | $342M | -20% | +3% | 4% | 0.9× | -4.2% | +5.4% |
| Indraprastha Medical INDRAMEDCO.NS | India | $351M | 0% | +11% | 15% | 1.9× | 14.9% | +19.3% |
| Viemed Healthcare VMD | United States | $333M | -9% | +22% | 8% | 1.1× | 6.8% | +15.5% |
| Q & M Dental Group (Singapore) QC7.SI | Singapore | $326M | -26% | +16% | 9% | 2.5× | 7.7% | +7.5% |
| Bayzed Health 2609.HK | Hong Kong | $375M | -58% | -2% | 5% | 2.4× | 14.7% | +9.2% |
| Bright Eye Hospital 301239.SZ | China | $377M | -26% | +11% | 9% | 1.3× | -5.1% | +15.5% |
| China Resources Medical 1515.HK | Hong Kong | $393M | -10% | 0% | 6% | 0.4× | -7.5% | +26.3% |
| Voxel VOX.WA | Poland | $393M | +59% | +14% | 24% | 2.7× | 1.2% | +12.2% |
| Charm Care 6062.T | Japan | $402M | +57% | +6% | 11% | 1.2× | -0.4% | +16.4% |
| Garofalo Health Care GHC.MI | Italy | $508M | -3% | +4% | 10% | 1.4× | 1.7% | +18.3% |
| Artemis Medicare Services ARTEMISMED.NS | India | $582M | +25% | +15% | 13% | 4.8× | 48.5% | +21.5% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | 4.1× | 17.4% | +18.1% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | 5.5× | 21.2% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 3.9× | n/a | n/a |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | 6.4× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | 0.9× | 6.1% | +6.0% |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 2.8× | 2.3% | +19.7% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 6.0× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 0.6× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 5.8× | 22.1% | +10.2% |